Drw Securities, LLC Cue Biopharma, Inc. Transaction History
Drw Securities, LLC
- $2.47 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding CUE
# of Institutions
55Shares Held
12.1MCall Options Held
25.6KPut Options Held
2.6K-
Bleichroeder LP New York, NY5MShares$7.45 Million1.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$3.06 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$1.13 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA631KShares$940,6080.0% of portfolio
-
Robertson Stephens Wealth Management, LLC San Francisco, CA479KShares$712,9650.02% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $52.7M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...